ShuYu Civilian Pharmacy Valuation

Q: What is the Fair Price of 301017 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

301017 (CN¥12.91) is trading above our estimate of [[fair value]] (CN¥1.11)

Is 301017 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 301017 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 301017 (CN¥12.91) is trading above our estimate of fair value (CN¥1.11)

Significantly Below Fair Value: 301017 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 301017?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for 301017. This is calculated by dividing 301017's market cap by their current preferred multiple.
What is 301017's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CN¥5.23b

301017 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.8x
Enterprise Value/EBITDA	25.9x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 301017's PE Ratio compare to its peers?

The above table shows the PE ratio for 301017 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	35.5x
605266 Jianzhijia Pharmaceutical Chain Group	16.7x	21.0%	CN¥6.5b
301408 Anhui Huaren Health Pharmaceutical	38.1x	n/a	CN¥5.1b
600833 Shanghai No.1 PharmacyLtd	26.7x	n/a	CN¥2.6b
300937 Sichuan Hezong Medicine Easy-to-buy Pharmaceutical	60.3x	n/a	CN¥2.2b
301017 ShuYu Civilian Pharmacy	66.2x	n/a	CN¥5.2b

Price-To-Earnings vs Peers: 301017 is expensive based on its Price-To-Earnings Ratio (66.2x) compared to the peer average (35.5x).

Price to Earnings Ratio vs Industry

How does 301017's PE Ratio compare vs other companies in the CN Consumer Retailing Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	30.4%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	30.4%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: 301017 is expensive based on its Price-To-Earnings Ratio (66.2x) compared to the CN Consumer Retailing industry average (29.5x).

Price to Earnings Ratio vs Fair Ratio

What is 301017's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

301017 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	66.2x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 301017's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.